Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Rinaldi

Showing results (171-180 of 231) with videos related to

Pageof 24
Sort By:
Cardiovascular Diabetology|March 6, 2019
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE StudyFerdinando Carlo Sasso, Pia Clara Pafundi, Raffaele Marfella, et al.
Journal of Clinical Medicine|November 14, 2023
Sepsis Outcome after Major Abdominal Surgery Does Not Seem to Be Improved by the Use of Pentameric Immunoglobulin IgM: A Single-Center Retrospective AnalysisAlessandro Perrella, Luca Rinaldi, Ilaria Guarino, et al.
Scientific Reports|April 7, 2022
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19Vincenzo Messina, Riccardo Nevola, Antonio Izzi, et al.
Infection|January 17, 2018
Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitisLuca Rinaldi, Antonio Ascione, Vincenzo Messina, et al.
Diabetes Research and Clinical Practice|March 25, 2019
High HDL cholesterol: A risk factor for diabetic retinopathy? Findings from NO BLIND studyFerdinando Carlo Sasso, Pia Clara Pafundi, Aldo Gelso, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 16, 2019
Liver fibrosis by FibroScan<sup>®</sup> independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetesRosa Lombardi, Lorena Airaghi, Giovanni Targher, et al.
Journal of Diabetes and Its Complications|August 25, 2020
NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetesRosa Lombardi, Lorena Airaghi, Giovanni Targher, et al.
World Journal of Diabetes|November 24, 2025
Impact of achieving glycated hemoglobin targets on cardiovascular events/mortality: <i>Post-hoc</i> analysis of the nephropathy in diabetes type 2 trialAlfredo Caturano, Vittorio Simeon, Raffaele Galiero, et al.
Scientific Reports|May 23, 2024
Long-COVID autonomic syndrome in working age and work ability impairmentLuca Rinaldi, Stefano Rigo, Margherita Pani, et al.
Acta Diabetologica|November 11, 2024
The impact of new onset diabetes on cardiovascular risks in orthotopic liver transplant recipients: findings from the COLT studyAlfredo Caturano, Anna di Martino, Gaetana Albanese, et al.
Pageof 24

Showing results (171-180 of 231) with videos related to

Sort By:
Pageof 24
Cardiovascular Diabetology|March 6, 2019
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE StudyFerdinando Carlo Sasso, Pia Clara Pafundi, Raffaele Marfella, et al.
Journal of Clinical Medicine|November 14, 2023
Sepsis Outcome after Major Abdominal Surgery Does Not Seem to Be Improved by the Use of Pentameric Immunoglobulin IgM: A Single-Center Retrospective AnalysisAlessandro Perrella, Luca Rinaldi, Ilaria Guarino, et al.
Scientific Reports|April 7, 2022
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19Vincenzo Messina, Riccardo Nevola, Antonio Izzi, et al.
Infection|January 17, 2018
Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitisLuca Rinaldi, Antonio Ascione, Vincenzo Messina, et al.
Diabetes Research and Clinical Practice|March 25, 2019
High HDL cholesterol: A risk factor for diabetic retinopathy? Findings from NO BLIND studyFerdinando Carlo Sasso, Pia Clara Pafundi, Aldo Gelso, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 16, 2019
Liver fibrosis by FibroScan<sup>®</sup> independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetesRosa Lombardi, Lorena Airaghi, Giovanni Targher, et al.
Journal of Diabetes and Its Complications|August 25, 2020
NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetesRosa Lombardi, Lorena Airaghi, Giovanni Targher, et al.
World Journal of Diabetes|November 24, 2025
Impact of achieving glycated hemoglobin targets on cardiovascular events/mortality: <i>Post-hoc</i> analysis of the nephropathy in diabetes type 2 trialAlfredo Caturano, Vittorio Simeon, Raffaele Galiero, et al.
Scientific Reports|May 23, 2024
Long-COVID autonomic syndrome in working age and work ability impairmentLuca Rinaldi, Stefano Rigo, Margherita Pani, et al.
Acta Diabetologica|November 11, 2024
The impact of new onset diabetes on cardiovascular risks in orthotopic liver transplant recipients: findings from the COLT studyAlfredo Caturano, Anna di Martino, Gaetana Albanese, et al.
Pageof 24